Prellis Biologics

History

2019: 3D - printing of vessels

In August, 2019 Prellis Biologics announced the beginning of printing on the 3D-printer of vascular structures and readiness to sell them to research organizations. It is the joint project with Volumetric Bio company.

Partners calculate that they will be able shortly to provide vaskulyarizirovanny skin transplants, insulin - the producing cages and vascular shunts which are grown up from tissue of patients.

Vessels began to print on the 3D-printer and to sell

According to the bioengineer Jordan Miller, earlier the impossibility 3D - printings of complex vascular network which could deliver nutrients in the recreated fabrics was one of the main obstacles in a way of creation of functional substitutes of fabrics. Besides, vascular networks of an organism interact among themselves physically and biochemical, and the architecture of vascular network is closely connected with function of body. Prellis Biologics and Volumetric Bio provided the first technology of bioprinting which solves a multivaskulyarization problem.

The technology developed by Miller and his command uses chemical reagents which react to light therefore certain sections of bioink harden, and others can be washed away. Researches were sponsored by Prellis Biologics which already announced that fabrics on the basis of the developed vascular frameworks were successfully implanted to several animals.

Researchers of a startup of Volumetric Bio provided free access to results of the experiences, however hope to commercialize technology, selling bioprinters, materials and reagents. Scientists from many pharmaceutical companies and the universities develop tests with the standardized fabric structures which are necessary for tests of medicines. Prellis represents to such researchers ready vascular frameworks for work on biological 3D-printing technologies.^[1]

Notes